Hutch News
Results per Page:
Fred Hutch science and research highlights 2019
Articles showcasing some of the most significant advances in immunotherapy, cell biology and more
New study aims to transform myeloma therapy into cure
$4M grant funds Dr. Geoffrey Hill’s bench-to-bedside research to enhance immune-boosting power of autologous blood stem cell transplantation
Failed Alzheimer’s drug boosts CAR T-cell therapy
Engineered immune cells get a helping hand in new clinical trial for multiple myeloma patients
Eliminating residual multiple myeloma with precision
From the Green Lab, Clinical Research Division
Dr. Tijana Martinov named a 2019 Parker Scholar
Early-career scientist will use funding for immunotherapy research in multiple myeloma
Fred Hutch collaborates with new Allen Institute for Immunology
Multi-collaborator initiative aims to map the immune system in health and disease
“Exciting” but early results in trial of immunotherapy for myeloma
Cancer cells disappeared rapidly in patients with high-risk, treatment-resistant disease
Standard myeloma treatment reveals itself as an immunotherapy
Mouse study shows how transplanting patients’ own healthy blood stem cells can curb cancer, opening door to better treatments
Good News: Fred Hutch joins coalition that seeks to increase transparency on life science career prospects
Celebrating faculty and staff achievements
A new option for high-risk multiple myeloma?
Study of three-step treatment approach reopens question of donor bone marrow transplant
Good News: Damian Green awarded $3.2M to test radioimmunotherapy for multiple myeloma ... and more
Celebrating faculty and staff achievements
‘A life changer’: Losing her partner to cancer helped shape Fred Hutch’s new chief human resources officer
Losing her partner to cancer helped shape life path for Fred Hutch’s new vice president and chief human resources officer
‘Finding their calling’: Cancer caregivers join larger cause after helping loved ones
Some family caregivers devote their lives to that larger work, shifting the health care landscape
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
Why prescription drugs cost twice as much in U.S. versus other advanced nations ― and what might be done about it
‘She’s like a sister to me’: Stem cell donor, recipient form lifelong bond
Stem cell donor and recipient form a lifelong bond
New guide helps patients, doctors make decisions on cancer drugs
ASCO ‘Value Framework’ offers a way to weigh health outcomes, side effects and costs of various treatments